| abstract |
A pharmaceutical composition and a method for the treatment of gastric disorders and Helicobacter pylori in the stomach or duodenum comprising a zinc compound and a cyclodextrin or cyclodextrin derivative for instance selected from α-cyclodextrin, β-cyclodextrin or η-cyclodextrin. The pharmaceutical composition may also include a pharmaceutically acceptable acidic compound such as a carboxylic acid. |